Free genome. Personal genome sharing between value production and subjectivization processes

Journal title SOCIOLOGIA DEL LAVORO
Author/s Mauro Turrini, Mattia Gallo
Publishing Year 2017 Issue 2017/145
Language Italian Pages 17 P. 202-218 File size 124 KB
DOI 10.3280/SL2017-145012
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

This paper aims to contribute to the debate on free labour by analysing the valorisation and subjectification processes implied in the practice of personal genomic data. The circulation and sharing of genomic data by individual users is here designed as a free and voluntary activity halfway between clinical labour and digital labour. The empirical material presented focus on the organizational and epistemological arrangements of these projects, on their proprietary statutes and methods of user participation.

L’articolo intende contribuire al dibattito sul free labour a partire dalle filiere del valore e dai processi di soggettivazione nell’ambito della produzione e del-la condivisione di dati genomici personali. La circolazione e la condivisione dei dati genomici da parte di singoli utenti viene qui studiata come una attività gratui-ta e volontaria a metà strada tra il lavoro clinico e il lavoro digitale. I materiali empirici presentati si focalizzano sulle strutture organizzative ed epistemologiche di questi progetti, in particolare sul loro statuto proprietario e sulle modalità di par-tecipazione degli utenti.

Keywords: Free labour, clinical labour, sharing economy, personal genomics

  1. Angrist M. (2012). Eyes wide open: the personal genome project, citizen science and Veracity in Informed Consent. Personalized Medicine, 6(6): 691-699.
  2. Balzano A. (2015). Biocapitale e potenza generativa postumana. Per una critica delle biotecnologie riproduttive transpecie. La camera blu. Rivista di studi di genere, 12. DOI: 10.6092/1827-9198/3666
  3. Barbrook R., Cameron A. (1996). Californian Ideology, Science as Culture, 6(1): 44-72.
  4. Becker G. (1964). Human Capital. New York: Columbia University.
  5. Becker G. (2007). Health as human capital: synthesis and extensions. Oxford Economic Papers, 59: 379-410.
  6. Benkler Y. (2006). The Wealth of Networks: How Social Production Transforms Markets and Freedom. New Haven: Yale University (trad. it. La ricchezza della Rete. La produzione sociale trasforma il mercato e aumenta le liberta. Milano: Università Bocconi, 2007).
  7. Birch K. (2016). Rethinking Value in the Bio-economy: Finance, Assetization, and the Management of Value. Science, Technology, & Human Values. DOI: 10.1177/0162243916661633
  8. Birch K., Tyfield D. (2012). Theorizing the Bioeconomy: Biovalue, Biocapital, Bioeconomics or… What? Science, Technology, & Human Values, 38(3): 299-327. DOI: 10.1177/0162243912442398
  9. Cardon D., Casilli A. (2015). Qu’est-ce que le Digital Labor? Paris: INA Éditions.
  10. Castells M. (2010). The Information Age: Economy, Society and Culture Volume 1: The Rise of the Network Society. Oxford: Wiley Blackwell.
  11. Caulfield T., McGuire A.L. (2012). Direct-to-Consumer Genetic Testing: Perceptions, Problems, and Policy Responses. Annual Review of Medicine, 63(1): 23-33.
  12. Church G.M. (2005). The personal genome project. Molecular Systems biology, 2005.0030.
  13. Cooper M. (2008). Experimental Labour: Offshoring Clinical Trials to China. East Asian Science, Technology and Society: an International Journal, 2(1): 73-92.
  14. Cooper M. (2008). Life as Surplus: Biotechnology and Capitalism in the Neoliberal Era. University of Washington: Seattle & London (trad. it. La vita come plusvalore. Biotecnologie e capitale al tempo del neoliberismo. Verona: Ombre Corte, 2013).
  15. Deleuze G. (1990). Post-scriptum sur les sociétés de contrôle. L’autre journal, n. 1, mai.
  16. Ducournau P., Beaudevin C. (2011). Génétique en ligne. Déterritorialisation des régulations de santé publique et formes de développement commercial. Anthropologie et sante. Revue internationale francophone d’anthropologie de la sante, 3: 1-18.
  17. Fuchs C. (2014). Digital Labour and Karl Marx. New York: Routledge. Fumagalli A. (2007). Bioeconomia e capitalismo cognitivo. Verso un nuovo paradigma di accumulazione. Roma: Carocci.
  18. Gillespie T. (2010). The politics of platform. New Media & Society, 12(3): 347-364. DOI: 10.1177/1461444809342738
  19. Grappi G., Turrini M. (2008). L’appropriazione e la valorizzazione della vita in sé La molteplicità strategica del biocapitale tra medicina e biotecnologie. Studi culturali, 5(3): 435-458. DOI: 10.1405/28270
  20. Harris A., Wyatt S., Kelly S.E. (2012). The Gift of Spit (and the Obligation To Return It): How consumers of online genetic testing services participate in research. Information, Communication & Society, 16(2): 236-257. DOI: 10.1080/1369118X.2012.701656
  21. Kera D. (2010). Bionetworking over DNA and Biosocial Interfaces: Connecting Policy and Design. Genomics, Society and Policy, 6(1): 47-60. DOI: 10.1186/1746-5354-6-1-47
  22. Levina M. (2010). Googling Your Genes: Personal Genomics and the Discourse of Citizen Bioscience in the Network Age. Journal of Science Communication, 9(1): 1-8.
  23. Lovink G. (2016), L’abisso dei social media. Nuove reti oltre l’economia dei like. Milano: Egea.
  24. McGowan M.L., Fishman J.R., Lambrix M.A. (2010). Personal genomics and individual identities: motivations and moral imperatives of early user. New Genetics and Society, 29(3): 261-290. DOI: 10.1080/14636778.2010.507485
  25. Mirowski P. (2012). The Modern Commercialization of Science as a Passel of Ponzi Schemes. Social Epistemology, 26(3-4): 285-310.
  26. Mitchell R., Waldby C. (2011). Le biobanche nazionali. Il lavoro clinico, la produzione del rischio e la creazione del biovalore. In: Turrini M., ed., Biocapitale. Vita e corpi nell’era del controllo biologico. Verona: Ombre corte: 71-97.
  27. Negri A., Vercellone C. (2007). Il rapporto capitale/lavoro nel capitalismo cognitivo. Posse, ottobre: 46-56.
  28. Nelkin D., Lindee S. (1995). The DNA mystique: The gene as a cultural icon. New York: W.H. Freeman.
  29. O’Riordan K. (2010). The Genome Incorporated: Constructing Biodigital Identity. Farnham (UK) & Burlington: Ashgate.
  30. O’Riordan K. (2011). Writing biodigital life: personal genomes and digital media. Biography, 34(1): 119-131. ISSN 0162-4962.
  31. Pistoi S. (2012). Il DNA incontra Facebook. Viaggio nel supermarket della genetica. Padova: Marsilio.
  32. Prainsack B. (2014), The Powers of Participatory Medicine. Plos Biology, 12(4).
  33. Rifkin J. (2014). The Zero Marginal Cost Society: The Internet of Things, the Collaborative Commons, and the Eclipse of Capitalism. New York: Palgrave MacMillan (trad. it. La societa a costo marginale zero. L’Internet delle cose, l’ascesa del Commons Collaborativo e l’eclissi del capitalismo. Milano: Mondadori, 2014).
  34. Rigi J., Prey R. (2015). Value, Rent, and the Political Economy of Social Media.
  35. The Information Society, 31(5): 392-406.
  36. Scholz T., a cura di (2013). Digital Labor: The Internet as Playground and Factory. New York: Routledge.
  37. Sharon T. (2016). The Googlization of health research: from disruptive innovation to disruptive ethics. Personalized Medicine, p. pme-2016-0057.
  38. Terranova T. (2000). Free Labor: Producing Culture for the Digital Economy. Social Text, 18(2): 33-58. DOI: 10.1215/01642472-18-2_63-33
  39. Turrini M. (2011). Biotecnologie, salute e lavoro clinico. In: Turrini M., Biocapitale. Vita e corpi nell’era del controllo biologico. Verona: Ombre Corte: 7-38.
  40. Turrini M. (2015). Practicing the biomedicine to come: Direct-to-consumer genetic testing, healthism and beyond. Ea - Journal of Medical Humanities & Social Studies of Science and Technology, 7(2): 49-69.
  41. Turrini M., Prainsack B. (2016). Beyond clinical utility: The multiple values of DTC genetics. Applied and Translational Genomics, 8: 4-8.
  42. Vercellone C. (2010). La loi de la valeur dans le passage du capitalisme industriel au capitalisme cognitif. European Journal of Economic and Social Systems, 23(2): 75-88.
  43. Wade N. (2007). Genome of DNA Discoverer Is Deciphered. New York Times.
  44. Waldby C. (2002). Stem Cells, Tissue Cultures and the Production of Biovalue. Health, 6(3): 305-323. DOI: 10.1177/136345930200600304
  45. Waldby C., Cooper M. (2008). The Biopolitics of Reproduction: Post-Fordist Biotechnology and Women’s Clinical Labour. Australian Feminist Studies. Taylor & Francis Group, 23(55): 57-73. DOI: 10.1080/08164640701816223
  46. Waldby C., Cooper M. (2014). Clinical Labor: Tissue Donors and Research Subjects in the Global Bioeconomy. Durham: Duke University (trad. it. Biolavoro globale. Corpi e nuova manodopera. Roma: DeriveApprodi, 2015).

Mauro Turrini, Mattia Gallo, Free genome. La condivisione del genoma personale tra produzione di valore e processi di soggettivazione in "SOCIOLOGIA DEL LAVORO " 145/2017, pp 202-218, DOI: 10.3280/SL2017-145012